dc.contributorPardo, Rosalba
dc.creatorLara Bernal, Marleny Aurora
dc.date.accessioned2019-02-11T16:41:00Z
dc.date.available2019-02-11T16:41:00Z
dc.date.created2019-02-11T16:41:00Z
dc.date.issued2019
dc.identifierhttp://repository.urosario.edu.co/handle/10336/19035
dc.identifierhttps://doi.org/10.48713/10336_19035
dc.description.abstractIntroduction: Diabetic ketoacidosis (CAD) in pediatrics is a common complication of diabetes mellitus type 1 (DM-1). Several factors influence the response to treatment and its metabolic behavior may vary according to whether the diabetic is known or is a debut. Objective: We describe the variables associated with CAD in patients under 18 years of age, including demographic, clinical, paraclinical characteristics, hospital stay and complications. Materials and methods: Cross-sectional study of a sample of 391 pediatric patients stratified by severity of CAD on admission between July 2007 and August 2018. Demographic, clinical, biochemical and omplications during the event (CAD) are described. Results: Of the 391 patients, 236 patients identified as known diabetics. 155 patients debut. Of the total 59.8% women vs 40.2% men. If CAD is classified by the pH value, the percentage of patients with mild CAD is 43.7% followed by moderate CAD 25.6% and severe CAD 30.7%, while if it is classified by the value of bicarbonate cases of CAD are predominantly moderate with 43.1%, followed by severe CAD with 28.3% and slight 28.1%. The stay of patients with CAD debut is greater both in hospitalization and in the intensive care unit. Conclusion: CAD has a different metabolic behavior and a degree of severity according to the variable used to classify it either pH or bicarbonate, using the bicarbonate values allows biochemically classifying the disorder more specifically, the most frequent complication was cerebral edema and it occurs in cases of severe CAD. The hospital stay is longer in cases of severe CAD.
dc.languagespa
dc.publisherUniversidad del Rosario
dc.publisherEspecialización en Cuidado Intensivo Pediátrico
dc.publisherFacultad de medicina
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAbierto (Texto Completo)
dc.rightsEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.
dc.sourceAndrade-Castellanos CA, Colunga-Lozano LE, Delgado-Figueroa N, Gonzalez-Padilla DA. Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis. Cochrane Database Syst Rev. 2016(1):CD011281.
dc.sourceFederation ID. IDF Diabetes Atlas: International Diabetes Federation; 2015. Available from: http://www.diabetesatlas.org/.
dc.sourceTamayo DC. Descripción de la epidemiología actual. Observatorio de Diabetes de Colombia [Internet]. 2013:[1-11 pp.]. Available from: http://www.odc.org.co/files/Diabetes_en_Colombia_descripcion_de_la_epidemiolo gia_actual.pdf.
dc.sourceBallesteros Calderón AL, Meneses Muñoz AP, Ríos Patiño D, Flórez Gómez ID, Quevedo Vélez A. Características epidemiológicas y clínicas y hallazgos de laboratorio de los niños menores de 15 años con cetoacidosis diabética atendidos en el Hospital Universitario San Vicente Fundación en Medellín, Colombia, entre enero de 2001 y diciembre de 2010. Iatreia. 2013;26(3):278-90.
dc.sourceAlzate Flórez JA, Alzate Ramos SA, Castaño Castrillón JJ, Gonzalez Cuartas J, Herrera Bustamante M, Herrera Muñoz V, et al. Morbimortalidad de los pacientes con cetoacidosis diabética que ingresaron a la unidad de cuidados intensivos pediátricos del Hospital Infantil Universitario de la Cruz Roja, Rafael Henao Toro, de la ciudad de Manizales (Colombia), 2004-2010. Archivos de medicina (Manizales). 2012;12(2):168-77.
dc.sourceLawrence SE, Cummings EA, Gaboury I, Daneman D. Population-based study of incidence and risk factors for cerebral edema in pediatric diabetic ketoacidosis. J Pediatr. 2005;146(5):688-92.
dc.sourceKordonouri O, Klingensmith G, Knip M, Holl RW, Aanstoot HJ, Menon PS, et al. ISPAD Clinical Practice Consensus Guidelines 2014. Other complications and diabetesassociated conditions in children and adolescents. Pediatr Diabetes. 2014;15 Suppl 20:270-8.
dc.sourceZucchini S, Scaramuzza AE, Bonfanti R, Buono P, Cardella F, Cauvin V, et al. A Multicenter Retrospective Survey regarding Diabetic Ketoacidosis Management in Italian Children with Type 1 Diabetes. J Diabetes Res. 2016;2016:5719470.
dc.sourceDhatariya KK, Nunney I, Higgins K, Sampson MJ, Iceton G. National survey of the management of Diabetic Ketoacidosis (DKA) in the UK in 2014. Diabet Med. 2016;33(2):252-60.
dc.sourceXu Y, Bai J, Wang G, Zhong S, Su X, Huang Z, et al. Clinical profile of diabetic ketoacidosis in tertiary hospitals in China: a multicentre, clinic-based study. Diabet Med. 2016;33(2):261-8.
dc.sourceLevin DL. Cerebral edema in diabetic ketoacidosis. Pediatr Crit Care Med. 2008;9(3):320-9.
dc.sourceArieff AI, Kleeman CR. Studies on mechanisms of cerebral edema in diabetic comas: effects of hyperglycemia and rapid lowering of plasma glucose in normal rabbits (J. Clin. Invest. 52:571-583, 1973). J Am Soc Nephrol. 2000;11(9):1776-88.
dc.sourceKennedy A, C., Linton AL, Luke RG, Renfrew S, Dinwoodie A. The Pathogenesis and Prevention of Cerebral Dysfunction During Dialysis. Lancet. 1964;1(7337):790-3.
dc.sourceProckop LD. Hyperglycemia, polyol accumulation, and increased intracranial pressure. Arch Neurol. 1971;25(2):126-40.
dc.sourceHarris GD, Fiordalisi I, Finberg L. Safe management of diabetic ketoacidemia. J Pediatr. 1988;113(1 Pt 1):65-8.
dc.sourceGlaser NS, Marcin JP, Wootton-Gorges SL, Buonocore MH, Rewers A, Strain J, et al. Correlation of clinical and biochemical findings with diabetic ketoacidosis-related cerebral edema in children using magnetic resonance diffusion-weighted imaging. J Pediatr. 2008;153(4):541-6.
dc.sourceKrane EJ, Rockoff MA, Wallman JK, Wolfsdorf JI. Subclinical brain swelling in children during treatment of diabetic ketoacidosis. N Engl J Med. 1985;312(18):1147-51.
dc.sourceHoffman WH, Steinhart CM, el Gammal T, Steele S, Cuadrado AR, Morse PK. Cranial CT in children and adolescents with diabetic ketoacidosis. AJNR Am J Neuroradiol. 1988;9(4):733-9.
dc.sourceSperling MA. Cerebral edema in diabetic ketoacidosis: an underestimated complication? Pediatr Diabetes. 2006;7(2):73-4.
dc.sourceYuen N, Anderson SE, Glaser N, Tancredi DJ, O'Donnell ME. Cerebral blood flow and cerebral edema in rats with diabetic ketoacidosis. Diabetes. 2008;57(10):2588-94.
dc.sourceWhalen MJ. Cerebrovascular autoregulation in diabetic ketoacidosis: time to go with the (microvascular cerebral blood) flow! Pediatr Crit Care Med. 2014;15(8):779-80.
dc.sourceHoffman WH, Stamatovic SM, Andjelkovic AV. Inflammatory mediators and blood brain barrier disruption in fatal brain edema of diabetic ketoacidosis. Brain Res. 2009;1254:138-48.
dc.sourceVavilala MS, Richards TL, Roberts JS, Chiu H, Pihoker C, Bradford H, et al. Change in blood-brain barrier permeability during pediatric diabetic ketoacidosis treatment. Pediatr Crit Care Med. 2010;11(3):332-8
dc.sourceGlaser N. Cerebral injury and cerebral edema in children with diabetic ketoacidosis: could cerebral ischemia and reperfusion injury be involved? Pediatr Diabetes. 2009;10(8):534-41.
dc.sourceGlaser NS, Tancredi DJ, Marcin JP, Caltagirone R, Lee Y, Murphy C, et al. Cerebral hyperemia measured with near infrared spectroscopy during treatment of diabetic ketoacidosis in children. J Pediatr. 2013;163(4):1111-6.
dc.sourceHoffman WH, Siedlak SL, Wang Y, Castellani RJ, Smith MA. Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis. Brain Res. 2011;1369:194- 202.
dc.sourceDekker TJ, Janson JA, Hoorn EJ, Sijpkens YW. [Fatal cerebral oedema during the treatment of diabetic ketoacidosis in an adult male]. Ned Tijdschr Geneeskd. 2017;161(0):D734.
dc.sourceGlaser NS, Ghetti S, Casper TC, Dean JM, Kuppermann N, Group PECARNPDFS. Pediatric diabetic ketoacidosis, fluid therapy, and cerebral injury: the design of a factorial randomized controlled trial. Pediatr Diabetes. 2013;14(6):435-46.
dc.sourceEdge JA, Jakes RW, Roy Y, Hawkins M, Winter D, Ford-Adams ME, et al. The UK casecontrol study of cerebral oedema complicating diabetic ketoacidosis in children. Diabetologia. 2006;49(9):2002-9.
dc.sourceBureau MA, Bégin R, Berthiaume Y, Shapcott D, Khoury K, Gagnon N. Cerebral hypoxia from bicarbonate infusion in diabetic acidosis. J Pediatr. 1980;96(6):968-73.
dc.sourceDurward A, Ferguson LP, Taylor D, Murdoch IA, Tibby SM. The temporal relationship between glucose-corrected serum sodium and neurological status in severe diabetic ketoacidosis. Arch Dis Child. 2011;96(1):50-7.
dc.sourceEdge JA, Ford-Adams ME, Dunger DB. Causes of death in children with insulin dependent diabetes 1990-96. Arch Dis Child. 1999;81(4):318-23.
dc.sourceRosenbloom AL. Intracerebral crises during treatment of diabetic ketoacidosis. Diabetes Care. 1990;13(1):22-33.
dc.sourceKarvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care. 2000;23(10):1516-26.
dc.sourceHarjutsalo V, Sund R, Knip M, Groop PH. Incidence of type 1 diabetes in Finland. Jama. 2013;310(4):427-8.
dc.sourceSvensson J, Cerqueira C, Kjærsgaard P, Lyngsøe L, Hertel NT, Madsen M, et al. Danish Registry of Childhood and Adolescent Diabetes. Clin Epidemiol. 2016;8:679-83.
dc.source11. Children and Adolescents (Standards of Medical Care in Diabetes—2016). Diabetes Care. 2016;39(Supplement 1):S86-S93.
dc.sourceDefinition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. Geneva: World Health Organization; 2006. Available from: http://www.who.int/diabetes/publications/diagnosis_diabetes2006/en/.
dc.source2. Classification and Diagnosis of Diabetes (Standards of Medical Care in Diabetes —2016). Diabetes Care. 2016;39(Supplement 1):S13-S22.
dc.sourceRewers A, Klingensmith G, Davis C, Petitti DB, Pihoker C, Rodriguez B, et al. Presence of diabetic ketoacidosis at diagnosis of diabetes mellitus in youth: the Search for Diabetes in Youth Study. Pediatrics. 2008;121(5):e1258-66.
dc.sourceGale EA. Dying of diabetes. Lancet. 2006;368(9548):1626-8.
dc.sourceHekkala A, Reunanen A, Koski M, Knip M, Veijola R, Register FPD. Age-related differences in the frequency of ketoacidosis at diagnosis of type 1 diabetes in children and adolescents. Diabetes Care. 2010;33(7):1500-2.
dc.sourceUsher-Smith JA, Thompson MJ, Sharp SJ, Walter FM. Factors associated with the presence of diabetic ketoacidosis at diagnosis of diabetes in children and young adults: a systematic review. BMJ. 2011;343:d4092.
dc.sourcede Vries L, Oren L, Lazar L, Lebenthal Y, Shalitin S, Phillip M. Factors associated with diabetic ketoacidosis at onset of Type 1 diabetes in children and adolescents. Diabet Med. 2013;30(11):1360-6.
dc.sourceRewers A, Chase HP, Mackenzie T, Walravens P, Roback M, Rewers M, et al. Predictors of acute complications in children with type 1 diabetes. JAMA. 2002;287(19):2511-8.
dc.sourceCurtis JR, To T, Muirhead S, Cummings E, Daneman D. Recent trends in hospitalization for diabetic ketoacidosis in ontario children. Diabetes Care. 2002;25(9):1591-6.
dc.sourceWolfsdorf JI, Allgrove J, Craig ME, Edge J, Glaser N, Jain V, et al. ISPAD Clinical Practice Consensus Guidelines 2014. Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2014;15 Suppl 20:154-79.
dc.sourceCorwell B, Knight B, Olivieri L, Willis GC. Current diagnosis and treatment of hyperglycemic emergencies. Emerg Med Clin North Am. 2014;32(2):437-52.
dc.sourceDunger DB, Sperling MA, Acerini CL, Bohn DJ, Daneman D, Danne TP, et al. ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child. 2004;89(2):188-94.
dc.sourceChase HP, Garg SK, Jelley DH. Diabetic ketoacidosis in children and the role of outpatient management. Pediatr Rev. 1990;11(10):297-304.
dc.sourceRosival V. Pathophysiology of diabetic ketoacidosis. Diabet Med. 2015;32(11):1527.
dc.sourceBotham KM, Mayes PA, Bender DA. Bioenergética y el metabolismo de carbohidratos y lípidos. In: de León Fraga J, editor. HARPER Bioquimica Ilustrada. 28a ed. Mexico: Mc Graw Hill; 2010. p. 92-224.
dc.sourceKomatsu M, Takei M, Ishii H, Sato Y. Glucose-stimulated insulin secretion: A newer perspective. J Diabetes Investig. 2013;4(6):511-6.
dc.sourceLeney SE, Tavaré JM. The molecular basis of insulin-stimulated glucose uptake: signalling, trafficking and potential drug targets. J Endocrinol. 2009;203(1):1-18.
dc.sourceNolan CJ, Madiraju MS, Delghingaro-Augusto V, Peyot ML, Prentki M. Fatty acid signaling in the beta-cell and insulin secretion. Diabetes. 2006;55 Suppl 2:S16-23.
dc.sourceBhattacharya S, Dey D, Roy SS. Molecular mechanism of insulin resistance. J Biosci. 2007;32(2):405-13.
dc.sourceKalsbeek A, la Fleur S, Fliers E. Circadian control of glucose metabolism. Mol Metab. 2014;3(4):372-83.
dc.sourceDonnelly D. The structure and function of the glucagon-like peptide-1 receptor and its ligands. Br J Pharmacol. 2012;166(1):27-41.
dc.sourceQuesada I, Tudurí E, Ripoll C, Nadal A. Physiology of the pancreatic alpha-cell and glucagon secretion: role in glucose homeostasis and diabetes. J Endocrinol. 2008;199(1):5-19.
dc.sourceSilber HE, Jauslin PM, Frey N, Karlsson MO. An integrated model for the glucoseinsulin system. Basic Clin Pharmacol Toxicol. 2010;106(3):189-94.
dc.sourcePatel SG, Hsu JW, Jahoor F, Coraza I, Bain JR, Stevens RD, et al. Pathogenesis of A⁻β⁺ ketosis-prone diabetes. Diabetes. 2013;62(3):912-22.
dc.sourceFeenstra RA, Kiewiet MK, Boerma EC, ter Avest E. Lactic acidosis in diabetic ketoacidosis. BMJ Case Rep. 2014;2014.
dc.sourceRosenbloom AL. Obesity, Insulin Resistance, beta-Cell Autoimmunity, and the Changing Clinical Epidemiology of Childhood Diabetes. Diabetes Care. 2003;26(10):2954-6.
dc.sourceFoster DW, McGarry JD. The metabolic derangements and treatment of diabetic ketoacidosis. N Engl J Med. 1983;309(3):159-69.
dc.sourceAbdulaziz S, Dabbagh O, Al Daker MO, Hassan I. Hypokalaemia and refractory asystole complicating diabetic ketoacidosis, lessons for prevention. BMJ Case Rep. 2012;2012.
dc.sourceCox K, Cocchi MN, Salciccioli JD, Carney E, Howell M, Donnino MW. Prevalence and significance of lactic acidosis in diabetic ketoacidosis. J Crit Care. 2012;27(2):132-7.
dc.sourceLinares MY, Schunk JE, Lindsay R. Laboratory presentation in diabetic ketoacidosis and duration of therapy. Pediatr Emerg Care. 1996;12(5):347-51.
dc.sourceNapolova O, Urbach S, Davids MR, Halperin ML. Assessing the degree of extracellular fluid volume contraction in a patient with a severe degree of hyperglycaemia. Nephrol Dial Transplant. 2003;18(12):2674-7.
dc.sourceHolliday MA, Segar WE. The maintenance need for water in parenteral fluid therapy. Pediatrics. 1957;19(5):823-32.
dc.sourceAl-Matrafi J, Vethamuthu J, Feber J. Severe acute renal failure in a patient with diabetic ketoacidosis. Saudi J Kidney Dis Transpl. 2009;20(5):831-4.
dc.sourceMitsuishi S, Matoba K, Yamazaki H. Acute respiratory distress syndrome in diabetic ketoacidosis. Intern Med. 2014;53(14):1581.
dc.sourceAboulhosn K, Arnason T. Acute pancreatitis and severe hypertriglyceridaemia masking unsuspected underlying diabetic ketoacidosis. BMJ Case Rep. 2013;2013.
dc.sourceCarmody D, Naylor RN, Philipson LH. Insulin dosing in pediatric diabetic ketoacidosis: where to start? JAMA. 2015;313(22):2274-5.
dc.sourceAl Hanshi S, Shann F. Insulin infused at 0.05 versus 0.1 units/kg/hr in children admitted to intensive care with diabetic ketoacidosis. Pediatr Crit Care Med. 2011;12(2):137-40.
dc.sourceDuhon B, Attridge RL, Franco-Martinez AC, Maxwell PR, Hughes DW. Intravenous sodium bicarbonate therapy in severely acidotic diabetic ketoacidosis. Ann Pharmacother. 2013;47(7-8):970-5.
dc.sourceMuir AB, Quisling RG, Yang MC, Rosenbloom AL. Cerebral edema in childhood diabetic ketoacidosis: natural history, radiographic findings, and early identification. Diabetes Care. 2004;27(7):1541-6.
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.subjectCetoacidosis
dc.subjectDiabetes mellitus
dc.subjectAcidosis metabólica
dc.subjectNiños
dc.subjectTratamiento
dc.titleCaracterización de pacientes pediátricos con cetoacidosis diabética de acuerdo a la presentación de la diabetes mellitus en hospitales de Colombia, 2017 – 2018
dc.typemasterThesis


Este ítem pertenece a la siguiente institución